Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Luspatercept in the Treatment of Beta Thalassemia in Italy: Lights and Shadows in Clinical Practice

Blood (2023) 142 (Supplement 1): 2475.

https://doi.org/10.1182/blood-2023-179747

Published: 2023

Journal Articles

Association between Native Myocardial T1 Mapping and Cardiac Function and Macroscopic Fibrosis in Thalassemia Major

Alessia Pepe, MD PhD, Nicola Martini, Antonio De Luca, Vincenzo Positano, Laura Pistoia, PhD, Giovan Battista Ruffo, Marilena Serra, MD, Calogera Gerardi, MD, Monica Benni, Crocetta Argento, Aurelio Maggio, MD, Gianfranco Sinagra, Antonella Meloni, PhD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-134585

Published: 2020

Journal Articles

New Film-Coated Tablet Formulation of Deferasirox Is Well Tolerated in Patients with Thalassemia or MDS: Results of the Randomized, Phase II E.C.L.I.P.S.E. Study

Ali T. Taher, MD PhD, Raffaella Origa, Silverio Perrotta, Alexandra Kouraklis, Giovan Battista Ruffo, Antonis Kattamis, MD, Ai-Sim Goh, Annelore Cortoos, Vicky Huang, Marine Weill, Raquel Merino Herranz, John B. Porter, BA MB BChir MRCP(Path) FRCP(Path) MD

Blood (2016) 128 (22): 1285.

https://doi.org/10.1182/blood.V128.22.1285.1285

Published: 2016

Journal Articles

Improved Patient-Reported Outcomes with a Film-Coated Versus Dispersible Tablet Formulation of Deferasirox: Results from the Randomized, Phase II E.C.L.I.P.S.E. Study

Blood (2016) 128 (22): 850.

https://doi.org/10.1182/blood.V128.22.850.850

Published: 2016

Journal Articles

Left Ventricular Global Function Index and Left Ventricular Mass Volume Ratio By CMR: Relation with Heart Failure in Thalassemia Major Patients

Antonella Meloni, PhD, Lucia De Franceschi, MD, Domenico Maddaloni, MD, Sabrina Carollo, MD, Roberto Sarli, MD, Carlo Cosmi, MD, Giovan Battista Ruffo, MD, Maria Giovanna Neri, PhD, Maria Chiara Resta, MD, Antonino Vallone, MD, Vincenzo Positano, MSc, Alessia Pepe, MD PhD

Blood (2014) 124 (21): 2688.

https://doi.org/10.1182/blood.V124.21.2688.2688

Published: 2014

Journal Articles

Myocardial Iron overload In Thalassemia Major. how Early To Check?

Caterina Borgna-Pignatti, MD, Antonella Meloni, PhD, Giulia Guerrini, MD, Aldo Filosa, MD, Giovan Battista Ruffo, MD, Tommaso Casini, MD, Nicola Romano, MD, Aurelio Maggio, MD, Elisabetta Chiodi, MD, Vincenzo Positano, MSc, Massimo Lombardi, MD, Alessia Pepe, MD, PhD

Blood (2013) 122 (21): 4703.

https://doi.org/10.1182/blood.V122.21.4703.4703

Published: 2013

Journal Articles

Myocardial and Hepatic Iron Overload and Cardiac Function In Sickle/Thalassemia Patients Of Italian Origin

Antonella Meloni, PhD, Giovan Battista Ruffo, MD, Daniele De Marchi, RT, Antonio Cardinale, MD, Anna Pietrapertosa, MD, Elena Facchini, MD, Patrizia Toia, MD, Lucia De Franceschi, MD, Vincenzo Positano, MSc, Massimo Lombardi, MD, Alessia Pepe, MD, PhD

Blood (2013) 122 (21): 2252.

https://doi.org/10.1182/blood.V122.21.2252.2252

Published: 2013

NARROW

Luspatercept in the Treatment of Beta Thalassemia in Italy: Lights and Shadows in Clinical Practice

Association between Native Myocardial T1 Mapping and Cardiac Function and Macroscopic Fibrosis in Thalassemia Major

New Film-Coated Tablet Formulation of Deferasirox Is Well Tolerated in Patients with Thalassemia or MDS: Results of the Randomized, Phase II E.C.L.I.P.S.E. Study

Improved Patient-Reported Outcomes with a Film-Coated Versus Dispersible Tablet Formulation of Deferasirox: Results from the Randomized, Phase II E.C.L.I.P.S.E. Study

Left Ventricular Global Function Index and Left Ventricular Mass Volume Ratio By CMR: Relation with Heart Failure in Thalassemia Major Patients

Myocardial Iron overload In Thalassemia Major. how Early To Check?

Myocardial and Hepatic Iron Overload and Cardiac Function In Sickle/Thalassemia Patients Of Italian Origin

Email alerts

ASH Publications

American Society of Hematology

Luspatercept in the Treatment of Beta Thalassemia in Italy: Lights and Shadows in Clinical Practice

Association between Native Myocardial T1 Mapping and Cardiac Function and Macroscopic Fibrosis in Thalassemia Major

New Film-Coated Tablet Formulation of Deferasirox Is Well Tolerated in Patients with Thalassemia or MDS: Results of the Randomized, Phase II E.C.L.I.P.S.E. Study

Improved Patient-Reported Outcomes with a Film-Coated Versus Dispersible Tablet Formulation of Deferasirox: Results from the Randomized, Phase II E.C.L.I.P.S.E. Study

Left Ventricular Global Function Index and Left Ventricular Mass Volume Ratio By CMR: Relation with Heart Failure in Thalassemia Major Patients

Myocardial Iron overload In Thalassemia Major. how Early To Check?

Myocardial and Hepatic Iron Overload and Cardiac Function In Sickle/Thalassemia Patients Of Italian Origin

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only